Bis(4-propan-2-yloxyphenyl)methanol | 870632-80-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Bis(4-propan-2-yloxyphenyl)methanol
• CAS: 870632-80-7
• 化学式: C₁₉H₂₄O₃
• 分子量: 300.398
• InChiKey: LLGRLIWHYGZSGP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  左旋环氧氯丙烷 、 Bis(4-propan-2-yloxyphenyl)methanol 在 四丁基硫酸氢铵 、 sodium hydroxide 作用下， 以 水 为溶剂， 生成
  参考文献：
  名称：

  Synthesis and evaluation of (S,S)-N,N′-bis-[3-(2,2′,6,6′-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity

  摘要：

  In order to identify new and potent candidate drugs to treat tuberculosis, a library of compounds was screened, and (S,S)-N,N '-bis-[3-(2,2 ',6,6 '-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) was identified as a hit in the screen. This research discusses our efforts to synthesize and test 30 analogs of this hit for activity against Mycobacterium tuberculosis. Two compounds with homopiperazine ring possess high in vitro activity against drug sensitive and resistant M. tuberculosis with MICs 0.78-3.13 mu g/mL (or 1.22-4.88 mu M). (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.09.035

文献信息

• [EN] PYRROLIDINE DERIVATIVES AS CB1-RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS DE PYRROLIDINE SERVANT D'ANTAGONISTES DU RÉCEPTEUR CB1
  申请人：TANABE SEIYAKU CO

  公开号：WO2005115977A1

  公开（公告）日：2005-12-08

  The present invention relates to a novel pyrrolidine compound, which has a potent antagonistic activity against central cannabinoid (CB1) receptor, having the formula [I]: wherein each of R1 and R2 is (A) optionally substituted aryl (or heteroaryl) group, or (B) both of the groups combine to form a group of the formula: one of R3 and R4 is hydrogen and another is hydrogen, hydroxyl, hydroxyalkyl, etc., or both of R3 and R4 combine to form oxo group, R5 is hydrogen or alkyl, Y is single bond, oxygen atom or a group of the formula: -N(R7)-, R6 is optionally substituted hydrocarbon group or optionally substituted cyclic group, R7 is alkyl or alkyloxycarbonylalkyl, provided that R6 is not 4-amino-5-chloro- 2-methoxyphenyl group when Y is single bond and one of the R3 and R4 is hydrogen and another is hydroxymethyl, or a pharmaceutically acceptable salt thereof.

  本发明涉及一种新型吡咯烷化合物，其对中枢大麻素（CB1）受体具有强效的拮抗活性，化学式为[I]：其中R1和R2中的每一个是（A）可选择取代的芳基（或杂环芳基）基团，或（B）两个基团结合形成下式的基团：R3和R4中的一个是氢，另一个是氢、羟基、羟基烷基等，或者R3和R4中的两个结合形成酮基团，R5是氢或烷基，Y是单键、氧原子或下式的基团：-N(R7)-，R6是可选择取代的烃基团或可选择取代的环烷基团，R7是烷基或烷氧羰基烷基，但要求当Y为单键且R3和R4中的一个是氢，另一个是羟甲基时，R6不是4-氨基-5-氯-2-甲氧基苯基团，或其药学上可接受的盐。
• Enantioselective alkylation of β-keto phosphonates by direct use of diaryl methanols as electrophiles
  作者：Masashi Shibata、Masahiro Ikeda、Kazuki Motoyama、Yoshihiro Miyake、Yoshiaki Nishibayashi

  DOI：10.1039/c2cc35262a

  日期：——

  Enantioselective alkylation of β-keto phosphonates with diaryl methanols in the presence of catalytic amounts of copper(II) trifluoromethanesulfonate and an optically active ligand gives the corresponding alkylated products in good to high yields with a high enantioselectivity.

  在催化量的三氟甲磺酸铜（II）和具有光学活性的配体存在下，δ-酮膦酸盐与二芳基甲醇的对映体选择性烷基化反应可得到相应的烷基化产物，产率从好到高，对映体选择性极高。
• Novel pyrrolidine compound and a process for preparing the same
  申请人：Moritani Yasunori

  公开号：US20070167440A1

  公开（公告）日：2007-07-19

  The present invention relates to a novel pyrrolidine compound, which has a potent antagonistic activity against central cannabinoid (CB1) receptor, having the formula [I]: wherein each of R 1 and R 2 is (A) optionally substituted aryl (or heteroaryl) group, or (B) both of the groups combine to form a group of the formula: one of R 3 and R 4 is hydrogen and another is hydrogen, hydroxyl, hydroxyalkyl, etc., or both of R 3 and R 4 combine to form oxo group, R 5 is hydrogen or alkyl, Y is single bond, oxygen atom or a group of the formula: —N(R 7 )—, R 6 is optionally substituted hydrocarbon group or optionally substituted cyclic group, R 7 is alkyl or alkyloxycarbonylalkyl, provided that R 6 is not 4-amino-5-chloro-2-methoxyphenyl group when Y is single bond and one of the R 3 and R 4 is hydrogen and another is hydroxymethyl, or a pharmaceutically acceptable salt thereof.

  本发明涉及一种新型吡咯烷化合物，其具有对中枢大麻素（CB1）受体的强烈拮抗活性，其化学式为[I]：其中，R1和R2中的每一个是（A）可选取的取代芳基（或杂环芳基）基团，或者（B）两个基团结合形成式的基团：R3和R4中的一个是氢，另一个是氢、羟基、羟基烷基等，或者R3和R4结合形成氧代基团，R5是氢或烷基，Y是单键、氧原子或式的基团：—N(R7)—，R6是可选取的取代的碳氢基团或可选取的取代的环状基团，R7是烷基或烷氧羰基烷基，但当Y为单键且R3和R4中的一个为氢，另一个为羟甲基时，R6不是4-氨基-5-氯-2-甲氧基苯基团，或其药学上可接受的盐。
• PYRROLIDINE DERIVATIVES AS CB1-RECEPTOR ANTAGONISTS
  申请人：TANABE SEIYAKU CO., LTD.

  公开号：EP1748980A1

  公开（公告）日：2007-02-07
• US8034949B2
  申请人：——

  公开号：US8034949B2

  公开（公告）日：2011-10-11